The proposed separation marks a significant pivot in Solventum’s three-phase transformation strategy. CEO Bryan Hanson noted that the move is intended to provide the software unit with the agility required to navigate a $10 billion market, while allowing the remaining Solventum structure to concentrate on its MedSurg and Dental Solutions portfolios. The Health Information Systems unit currently serves over 75% of U.S. hospitals, processing roughly 660 million clinical documents every month.
Management is evaluating various separation pathways, including a potential independent public listing or a merger with another industry player. While the company has set a target completion window of 12 to 18 months, officials cautioned that no final structure has been decided and the process remains subject to board and regulatory approvals. Morgan Stanley and Goldman Sachs are serving as financial advisors to the company during this transition.

Comments (0)
No comments yet. Be the first!